The GPR40 Full Agonist SCO-267 Improves Liver Parameters in a Mouse Model of Nonalcoholic Fatty Liver Disease without Affecting Glucose or Body Weight (vol 375, pg 21, 2020)

被引：0
|
作者：
Ookawara, M.
Matsuda, K.
Watanabe, M.
Moritoh, Y.
机构：
来源：
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 2020年 / 375卷 / 01期
关键词：
D O I：
10.1124/jpet.120.000046err
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：237 / 237
页数：1
相关论文
共 4 条
  • [1] The GPR40 Full Agonist SCO-267 Improves Liver Parameters in a Mouse Model of Nonalcoholic Fatty Liver Disease without Affecting Glucose or Body Weight
    Ookawara, Mitsugi
    Matsuda, Keisuke
    Watanabe, Masanori
    Moritoh, Yusuke
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2020, 375 (01): : 21 - 27
  • [2] SCO-267, a GPR40 Full Agonist, Improves Glycemic and Body Weight Control in Rat Models of Diabetes and Obesity
    Ueno, Hikaru
    Ito, Ryo
    Abe, Shin-ichi
    Ookawara, Mitsugi
    Miyashita, Hirohisa
    Ogino, Hitomi
    Miyamoto, Yasufumi
    Yoshihara, Tomoki
    Kobayashi, Akihiro
    Tsujihata, Yoshiyuki
    Takeuchi, Koji
    Watanabe, Masanori
    Yamada, Yukio
    Maekawa, Tsuyoshi
    Nishigaki, Nobuhiro
    Moritoh, Yusuke
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2019, 370 (02): : 172 - 181
  • [3] SCO-267, a GPR40 Full Agonist, Improves Glycemic and Body Weight Control More Than That by Fasiglifam in Rat Models of Diabetes and Obesity
    Moritoh, Yusuke
    Ueno, Hikaru
    Ito, Ryo
    Abe, Shin-Ichi
    Miyashita, Hirohisa
    Ogino, Hitomi
    Ookawara, Mitsugi
    Ishimura, Yoshimasa
    Miyamoto, Yasufumi
    Yoshihara, Tomoki
    Tsujihata, Yoshiyuki
    Takeuchi, Koji
    Nishigaki, Nobuhiro
    Yamada, Yukio
    Watanabe, Masanori
    DIABETES, 2019, 68
  • [4] SCO-267, a GPR40 Full Agonist, Stimulates Islet and Gut Hormone Secretion and Improves Glycemic Control in Humans (vol 70, pg 2364, 2021)
    Nishizaki, Harunobu
    Matsuoka, Osamu
    Kagawa, Tomoya
    Kobayashi, Akihiro
    Watanabe, Masanori
    Moritoh, Yusuke
    DIABETES, 2022, 71 (01) : 171 - 171
1